Trial for Harm Reduction With Incentives & Vaping E-cigarettes
THRIVE
Harm Reduction in Smokers With Obesity: Impact of Contingent Incentives and E-Cigarettes
2 other identifiers
interventional
39
1 country
1
Brief Summary
The purpose of this study is to provide preliminary information on the effect of electronic nicotine delivery systems (ENDS) provisions and contingent incentives (CI) on smoking in individuals with overweight/obesity who smoke cigarettes (SWO). All participants will be provided information on the comparative risk of ENDS relative to cigarette smoking, and a randomized group of participants will be provided ENDS provisions for 6 weeks. All participants will complete breath samples for 28 days to measure their exhaled carbon monoxide and will either receive fixed incentives for sample completion or receive varying incentives contingent on their carbon monoxide levels. Researchers will compare groups to understand the effect of each condition on smoking-related behavior.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable obesity
Started Nov 2023
Shorter than P25 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 20, 2023
CompletedFirst Posted
Study publicly available on registry
November 1, 2023
CompletedStudy Start
First participant enrolled
November 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 28, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 28, 2024
CompletedNovember 18, 2024
November 1, 2024
10 months
October 20, 2023
November 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Use of Cigarettes and ENDS
Daily use of cigarettes and ENDS will be determined using the Timeline Follow-Back (TLFB) in follow-up assessments post-treatment.
Assessed 4, 6, and 12 weeks follow-up
Within-Treatment Smoking Abstinence
Number of days during the incentive period with CO verified abstinence from smoking
Daily for 4 weeks
Secondary Outcomes (5)
Motivation to change
Assessed 4, 6, and 12 weeks follow-up
Carbon monoxide (CO)
Assessed 4, 6, and 12 weeks follow-up
Cigarette and E-Cigarette Dependence
Assessed 4, 6, and 12 weeks follow-up
Comparing E-Cigarettes and Cigarettes Questionnaire
Assessed 4, 6, and 12 weeks follow-up
Weight
Assessed 4, 6, and 12 weeks follow-up
Study Arms (4)
ENDS and CI
EXPERIMENTALParticipants in this arm will receive information about the comparative risk of electronic nicotine delivery systems (ENDS) relative to smoking as well as 6 weeks' worth of provisions of ENDS and will receive 4 weeks of monetary incentives for complete abstinence from smoking (after a controlled ramp down of smoking).
No ENDS and CI
EXPERIMENTALParticipants in this arm will receive information about the comparative risk of electronic nicotine delivery systems (ENDS) relative to smoking and will receive 4 weeks of monetary incentives for complete abstinence from smoking (after a controlled ramp down of smoking).
ENDS and NI
EXPERIMENTALParticipants in this arm will receive information about the comparative risk of electronic nicotine delivery systems (ENDS) relative to smoking as well as 6 weeks' worth of provisions of ENDS and will receive monetary incentives for providing breath samples only (non-contingent on smoking status).
No ENDS and NI
EXPERIMENTALParticipants in this arm will receive information about the comparative risk of electronic nicotine devices (ENDs) relative to smoking and will receive monetary incentives for providing breath samples only (non-contingent on smoking status).
Interventions
Participants in active comparator groups that include ENDS will receive 6-weeks worth of ENDS supplies.
Participants in active comparator groups will receive incentives that vary based on participant abstinence from smoking, measured by a carbon monoxide breath sample.
Participants in active comparator groups labeled No ENDS will only receive information about the comparative risk of ENDS relative to combustible cigarettes.
Participants in active comparator groups labeled NI will receive compensation for each breath sample provided throughout the study, with no variation.
Eligibility Criteria
You may qualify if:
- BMI ≥ 25 kg/m2
- smoked ≥ 5 cigarettes/day during the past year
- or older
- exhaled CO of \> 6 ppm at Baseline
- willing to use ENDs for 6 weeks
- daily access to a Bluetooth-enabled smartphone/tablet
You may not qualify if:
- planning to set a smoking quit date in the next 30 days
- receiving smoking cessation treatment of any kind in the past 30 days
- currently using ENDS \> 4 day per month
- hospitalized for mental illness in past 30 days
- heart-related event (e.g., heart attack, severe angina) in past 30 days
- resides with another person enrolled in the study
- pregnant, nursing, or planning to become pregnant in the next 6 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Brown University School of Public Health
Providence, Rhode Island, 02912, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cara M Murphy, Ph.D.
Brown University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessor will not know the outcome of randomized assignment.
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 20, 2023
First Posted
November 1, 2023
Study Start
November 1, 2023
Primary Completion
August 28, 2024
Study Completion
August 28, 2024
Last Updated
November 18, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Clinical Laboratory Core data collected to fulfill the aims of the Center for Addiction and Disease Risk Exacerbation will be available to request immediately following publication with no prespecified end date.
- Access Criteria
- After all data are collected and the results of the study are published, deidentified data and biospecimens may be made available to other qualified investigators at Brown or other institutions upon request. The request will be evaluated by the investigators to ensure that it meets reasonable demands of scientific integrity.
Deidentified data will be kept and used for future research on chronic disease and substance use.